 |
|
|
| |
Change in Vitamin D Levels Smaller and Risk of Development of Severe Vitamin D Deficiency Lower Among HIV-1-Infected, Treatment-naïve Adults Receiving TMC278 Compared with Efavirenz: 48-week Results from the Phase III ECHO Trial
|
| |
| |
Reported by Jules Levin
CROI 2011 March 2 Boston
D Wohl,1 M Doroana,2 C Orkin,3 JH Pilotto,4 S Sungkanuparph,5 P Yeni,6
S Vanveggel,7 H Deckx,7 K Boven8
1The Center for AIDS Research, The University of North Carolina at Chapel Hill, NC, USA;
2Hospital de Santa Maria, Lisbon, Portugal; 3Barts and the London NHS Trust, London, UK;
4Hospital Geral de Novo Iguacu, Novo Iguacu, Brazil; 5Infectious Disease, Faculty of Medicine, Ramathibodi Hospital, Thailand; 6Hopital Bichat, Paris, France; 7Tibotec BVBA, Beerse, Belgium;
8Tibotec Inc., Titusville, NJ, USA
|
| |
|
|
|
|
|
